| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.026 | 0.6 |